LSBWF · LakeShore Biopharma Co., Ltd. · Financials
Market Cap
$2.76M
Shares
41.21M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Diluted EPS
-$0.73
-28.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| USD/shares | -$0.73 | -$0.57 | -$0.23 | — | — |
| USD/shares | -$0.73 | -$0.57 | -$0.23 | — | — |
| shares | 19.16M | 10.69M | 6.18M | 61.83M | 61.83M |
| shares | 19.16M | 10.69M | 6.18M | 61.83M | 61.83M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.73×
EV/EBIT
—
P/E (TTM)
—
Peer medians compare against the 136 similar-size Biotechnology companies (of 533 listed).